Kang, B.; Mottamal, M.; Zhong, Q.; Bratton, M.; Zhang, C.; Guo, S.; Hossain, A.; Ma, P.; Zhang, Q.; Wang, G.;
et al. Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer. Pharmaceuticals 2023, 16, 735.
https://doi.org/10.3390/ph16050735
AMA Style
Kang B, Mottamal M, Zhong Q, Bratton M, Zhang C, Guo S, Hossain A, Ma P, Zhang Q, Wang G,
et al. Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer. Pharmaceuticals. 2023; 16(5):735.
https://doi.org/10.3390/ph16050735
Chicago/Turabian Style
Kang, Borui, Madhusoodanan Mottamal, Qiu Zhong, Melyssa Bratton, Changde Zhang, Shanchun Guo, Ahamed Hossain, Peng Ma, Qiang Zhang, Guangdi Wang,
and et al. 2023. "Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer" Pharmaceuticals 16, no. 5: 735.
https://doi.org/10.3390/ph16050735
APA Style
Kang, B., Mottamal, M., Zhong, Q., Bratton, M., Zhang, C., Guo, S., Hossain, A., Ma, P., Zhang, Q., Wang, G., & Payton-Stewart, F.
(2023). Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer. Pharmaceuticals, 16(5), 735.
https://doi.org/10.3390/ph16050735
